Market Samachar
Home  ›  INDIAN
Language Englishతెలుగుहिन्दीதமிழ்मराठीবাংলাಕನ್ನಡ
NDTV PROFIT - LATEST · INDIAN ·

Novo Shares Plunge 6% Despite CagriSema Beating Lilly In Diabetes Trial

As reported by NDTV Profit - Latest
CagriSema is a weekly injection that blends cagrilintide, a compound that mimics the pancreatic hormone amylin, with semaglutide, the active component in Wegovy.
▸ MARKET SAMACHAR VIEW
NEUTRAL
Read full article on NDTV Profit - Latest ↗

Market Samachar is a news aggregator. This article was originally published by NDTV Profit - Latest. Tap the button above to read the full story on their site.

🔥 Hot Now
Top stories across markets in the last hour

More from Market Samachar